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Propositions
Genome wide characterization of minimally differentiated acute myeloid leukemia
Among the 1. RUNX1 mutations, point mutations of the biallelic type are associated with 
the AML-M0 subtype (Oncogene 2004; 23:4284-4296).
Homozygosity of 2. RUNX1 mutations in AML-M0 occurs mainly via a mechanism 
leading to partial isodisomy, probably chromosomal recombination (this thesis).
Trisomy 13 is correlated with 3. RUNX1 mutation. It is likely that the co-occurrence of 
these mutations results in a four fold increase of FLT3 expression (this thesis).
Until this date, 4. ETV6 is the only hematopoietic transcription factor frequently found 
mutated in AML-M0 patients other than RUNX1 (this thesis).
Gene expression profiling shows that 5. RUNX1 mutation is associated with expression of 
(early) B-lymphocyte associated genes (this thesis).
TdT expression may serve as a marker for 6. RUNX1 mutation in AML-M0 (this thesis).
The number of cancer genes is much larger than previously anticipated (7. Nature 2007; 
446:153-158).
Further research in acute myeloid leukemia is necessary as increases in patient life 8. 
expectancy are mainly due to improvements in supportive care and not in treatment 
(Nature 2008; 456:66-72).
Whole-genome sequencing will be essential for cancer diagnosis and therapy (9. Science 
2008; 321:1801-1806).
One’s view defines what one sees.10. 
Change starts with oneself.11. 
Life is like a relay where one takes their turn during a given time. So is Science.12. 
Science does not give all the answers.13. 
‘Entia non sunt multiplicanda praeter necessitatem’ or ‘All other things being equal, the 14. 
simplest solution is the best’ (Ockham’s razor).
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